Biotin Derivatives for Mild Streptavidin Dissociation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The interaction between biotin and streptavidin is practically irreversible, requiring harsh conditions for dissociation, which is not suitable for maintaining the integrity or viability of proteins or cells during purification processes.
Innovation Solution
Development of biotin derivatives with reduced affinity for streptavidin, allowing for separation under less harsh conditions, including specific chemical modifications and synthesis methods to alter the dissociation constant, enabling easier release without damaging attached moieties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If biotin is used to capture entities from streptavidin, then the binding affinity is extremely high (KD about 10^-15 M), but the dissociation requires harsh conditions such as strong acid, detergent, and high temperature
Solution Approach 1:
The patent modifies the chemical structure of biotin by introducing substituents at specific positions (e.g., position 3, 4, or 6) to change the binding affinity parameters. This allows tuning the KD value to achieve a balance between strong binding for capture and easier dissociation under milder conditions compared to native biotin.
Solution Approach 2:
The biotin molecule is chemically modified by adding substituent groups at specific positions, effectively segmenting the original biotin structure into a core biotin scaffold with functionalizing groups. This segmentation allows independent optimization of binding strength and dissociation conditions.
2Ease of operation
If harsh conditions are used to release biotin from streptavidin, then the dissociation can occur, but the structural integrity and viability of attached moieties are compromised
Solution Approach 1:
By changing the chemical parameters of biotin through substitution at specific positions, the patent creates derivatives that dissociate under milder conditions. This allows release of captured entities without subjecting them to harsh acid, detergent, or high temperature treatments that would damage their structural integrity.
Solution Approach 2:
The modified biotin derivative acts as an intermediary that facilitates controlled dissociation. The substituent groups introduced into the biotin structure serve as mediators that enable reversible binding and controlled release under gentler conditions, protecting the integrity of attached moieties while still allowing effective capture.
3Object-affected harmful factors
If biotin derivatives with reduced affinity are developed, then dissociation under milder conditions is achieved, but the binding strength for capture is reduced
Solution Approach 1:
The patent systematically varies chemical parameters by introducing different substituents at specific positions of the biotin molecule. This allows precise tuning of the binding affinity parameter to achieve an optimal balance: strong enough binding for effective capture, but weak enough to allow dissociation under milder conditions compared to native biotin.
Solution Approach 2:
The patent creates biotin derivatives with tunable binding characteristics that provide dynamic control over the binding interaction. The modified structures allow the system to transition from strong binding during capture to controlled dissociation under mild conditions, providing flexibility in the capture-release cycle.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biotin derivatives facilitate the separation of biotin-containing entities from streptavidin under milder conditions, preserving the structural integrity and viability of proteins and cells, making them suitable for applications where harsh conditions are undesirable.
Implementation Method 1
The interaction between biotin and avidin or streptavidin is considered to be practically irreversible. Biotin has a affinity constant, or KD, for avidin of about 10−15 M.
Implementation Method 2
the biotin derivatives can be separated from streptavidin under less harsh conditions than are required for biotin
Data Source
AI summary
Biotin derivatives, methods of using the biotin derivatives and kits comprising the biotin derivatives.


